首页> 外文OA文献 >Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study

【2h】

Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study

机译：用口服基质金属蛋白酶抑制剂进行备注治疗抑制乳腺癌转移：临床前验证原则研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Arthur Winer; Maxwell Janosky; Beth Harrison; Judy Zhong; Dariush Moussai; Pinar Siyah; Nina Schatz-Siemers; Jennifer Zeng; Sylvia Adams; Paolo Mignatti;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study [J] . Winer Arthur, Janosky Maxwell, Harrison Beth, Molecular cancer therapeutics . 2016,第10期

机译：口服基质金属蛋白酶抑制剂通过术前治疗抑制乳腺癌转移：一项临床前原则研究
2. Matrix metalloproteinase inhibitor RO 28-2653 decreases liver metastasis by reduction of MMP-2 and MMP-9 concentration in BOP-induced ductal pancreatic cancer in Syrian Hamsters: inhibition of matrix metalloproteinases in pancreatic cancer. [J] . Kilian M, Gregor JI, Heukamp I, Prostaglandins, Leukotrienes, and Essential Fatty Acids . 2006,第6期

机译：基质金属蛋白酶抑制剂RO 28-2653通过降低叙事仓鼠BOP诱发的导管胰腺癌中MMP-2和MMP-9的浓度来降低肝转移：胰腺癌中基质金属蛋白酶的抑制。
3. Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. [J] . Martin MD, Carter KJ, Jean-Philippe SR, Cancer research: The official organ of the American Association for Cancer Research, Inc . 2008,第15期

机译：乳腺癌模型中消融或抑制基质金属蛋白酶9对肺转移的影响取决于遗传背景。
4. PERACETYLATED EPIGALLOCATECHIN-3-GALLATE EFFECTIVELY PREVENTS HUMAN BREAST CANCER CELL METASTASIS BY TARGETING THE MATRIX METALLOPROTEINASES ACTIVITY AND FATTY ACID SYNTHASE EXPRESSION [C] . Yi-Shiou Chiou, Nianhan Jia-Lin Ma, Shengmin Sang International Flavor Conference . 2013

机译：通过靶向基质金属蛋白酶活性和脂肪酸合成酶表达，有效地防止人乳腺癌细胞转移有效预防人乳腺癌细胞转移
5. Inhibition of matrix metalloproteinases in a human breast cancer xenograft model. [D] . Low, Jennifer Ann. 1998

机译：在人类乳腺癌异种移植模型中基质金属蛋白酶的抑制作用。
6. INHIBITION OF BREAST CANCER METASTASIS BY PRESURGICAL TREATMENT WITH AN ORAL MATRIX METALLOPROTEINASE INHIBITOR: A PRECLINICAL PROOF-OF-PRINCIPLE STUDY [O] . Arthur Winer, Maxwell Janosky, Beth Harrison, -1

机译：口服基质金属蛋白酶抑制剂的术前治疗抑制乳腺癌的转移：一项临床前证据证明
7. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. [O] . Yoneda, T, Sasaki, A, Dunstan, C, 1997

机译：通过双膦酸盐伊班膦酸盐和基质金属蛋白酶-2的组织抑制剂联合治疗抑制乳腺癌的溶骨性骨转移。
8. Novel Tissue Inhibitor of Metalloproteinase, TIMP-4, in Human Breast Cancer Growth and Metastasis [R] . Shi, Y. E. 2000

机译：新型组织金属蛋白酶抑制剂TImp-4在人乳腺癌生长和转移中的应用

Inhibition of Breast Cancer Metastasis by Presurgical Treatment with an Oral Matrix Metalloproteinase Inhibitor: A Preclinical Proof-of-Principle Study

著录项

引文网络

相似文献

相关主题

期刊订阅